JP2006513247A5 - - Google Patents

Download PDF

Info

Publication number
JP2006513247A5
JP2006513247A5 JP2004566646A JP2004566646A JP2006513247A5 JP 2006513247 A5 JP2006513247 A5 JP 2006513247A5 JP 2004566646 A JP2004566646 A JP 2004566646A JP 2004566646 A JP2004566646 A JP 2004566646A JP 2006513247 A5 JP2006513247 A5 JP 2006513247A5
Authority
JP
Japan
Prior art keywords
acid
amino
substituted bile
compound
bile acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004566646A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006513247A (ja
JP4610345B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/041656 external-priority patent/WO2004062574A2/en
Publication of JP2006513247A publication Critical patent/JP2006513247A/ja
Publication of JP2006513247A5 publication Critical patent/JP2006513247A5/ja
Application granted granted Critical
Publication of JP4610345B2 publication Critical patent/JP4610345B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004566646A 2003-01-13 2003-12-24 医薬品化合物のための改善されたリンカー Expired - Fee Related JP4610345B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43972203P 2003-01-13 2003-01-13
PCT/US2003/041656 WO2004062574A2 (en) 2003-01-13 2003-12-24 Improved linkers for radiopharmaceutical compounds

Publications (3)

Publication Number Publication Date
JP2006513247A JP2006513247A (ja) 2006-04-20
JP2006513247A5 true JP2006513247A5 (https=) 2007-02-15
JP4610345B2 JP4610345B2 (ja) 2011-01-12

Family

ID=32713508

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004566646A Expired - Fee Related JP4610345B2 (ja) 2003-01-13 2003-12-24 医薬品化合物のための改善されたリンカー

Country Status (9)

Country Link
US (2) US7989417B2 (https=)
EP (1) EP1583564B1 (https=)
JP (1) JP4610345B2 (https=)
CN (1) CN100534535C (https=)
AT (1) ATE435035T1 (https=)
AU (1) AU2003303714B2 (https=)
CA (1) CA2512310C (https=)
DE (1) DE60328226D1 (https=)
WO (1) WO2004062574A2 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7922998B2 (en) * 2003-01-13 2011-04-12 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US8420050B2 (en) * 2003-01-13 2013-04-16 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
CA2512310C (en) * 2003-01-13 2012-09-25 Bracco Imaging S.P.A. Improved linkers for radiopharmaceutical compounds
US7850947B2 (en) 2003-01-13 2010-12-14 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7611692B2 (en) * 2003-01-13 2009-11-03 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7226577B2 (en) 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
CA2549318A1 (en) * 2003-12-24 2005-07-28 Enrico Cappelletti Improved gastrin releasing peptide compounds
AU2005265048B2 (en) * 2004-06-18 2011-06-16 Elamleh, David R. Intravascular imaging device and uses thereof
KR20090014164A (ko) * 2006-04-19 2009-02-06 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 세포 영상화 및 치료를 위한 조성물 및 방법
US8758723B2 (en) * 2006-04-19 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for cellular imaging and therapy
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
EP2604284A1 (en) * 2007-02-16 2013-06-19 KTB Tumorforschungsgesellschaft mbH Receptor And Antigen Targeted Prodrug
WO2008144728A1 (en) * 2007-05-21 2008-11-27 Bracco Imaging S.P.A. Conjugates which bind a blood protein such as human serum albumin and methods of using the same in diagnostic and therapeutic applications
EP2895204B1 (en) 2012-09-13 2020-10-21 Provincial Health Services Authority Compositions targeting bradykinin receptor b1 for medical imaging of cancer and other disorders
CN104744568B (zh) * 2013-12-25 2018-02-23 华东理工大学 对神经激肽‑1受体蛋白特异性识别的p物质多肽探针及其制备与应用
GB201417067D0 (en) 2014-09-26 2014-11-12 South African Nuclear Energy Radiopharmaceutical conjugate
US20190029637A1 (en) * 2016-01-29 2019-01-31 The Regents Of The University Of California A wearable sensor, and method, to monitor anti-coagulation therapy
CN109970834A (zh) * 2019-02-27 2019-07-05 郑州明泽医药科技有限公司 一种氢化可的松琥珀酸钠的制备方法
CN112067556B (zh) * 2020-09-29 2021-08-17 湖北鑫英泰系统技术股份有限公司 一种油浸式设备油气检测方法及装置

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
US5534497A (en) * 1986-05-28 1996-07-09 Mallinckrodt Medical, Inc. Technetium chelates to be used for determining the renal function
AU618029B2 (en) * 1987-11-02 1991-12-12 Imperial Chemical Industries Plc Polypeptide compounds
US4988496A (en) * 1988-05-31 1991-01-29 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US5686410A (en) * 1989-07-20 1997-11-11 Novartis Ag Polypeptide derivatives
ES2070329T3 (es) 1989-07-20 1995-06-01 Sandoz Ltd Derivados de polipeptidos.
DE3930696A1 (de) * 1989-09-14 1991-03-28 Hoechst Ag Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel
US5217955A (en) * 1989-09-15 1993-06-08 Biomeasure, Inc. Treatment of cancer with peptide analog of bombesin, grp, litorin or neuromedin
US5811387A (en) * 1990-05-15 1998-09-22 Chiron Corporation Peptoid mixtures
US5834433A (en) * 1990-07-26 1998-11-10 Merrell Pharmaceuticals Inc. Compounds and pharmaceutical uses of peptides of bombesin and GRP
US5620959A (en) * 1990-07-31 1997-04-15 Glaxo Wellcome Inc. Bombesin antagonists
US5369094A (en) * 1990-11-29 1994-11-29 The Administrators Of The Tulane Educational Fund Polypeptide bombesin antagonists
US5244883A (en) * 1990-11-29 1993-09-14 The Administrators Of The Tulane Educational Fund Nonapeptide bombesin antagonists
AU659659B2 (en) * 1991-05-23 1995-05-25 Merrell Dow Pharmaceuticals Inc. Bombesin analogs
EP0626973A1 (en) * 1992-02-07 1994-12-07 Merrell Pharmaceuticals Inc. Phenylalanine analogs of bombesin
US5620955A (en) * 1993-06-18 1997-04-15 Peptide Technologies Corporation Bombesin receptor antagonists and uses thereof
US5410018A (en) * 1994-02-25 1995-04-25 Oregon Regional Primate Research Center Bombesin-related peptides
US5662885A (en) 1994-07-22 1997-09-02 Resolution Pharmaceuticals Inc. Peptide derived radionuclide chelators
US5753206A (en) * 1995-06-07 1998-05-19 Immunomedics, Inc. Radiometal-binding analogues of luteinizing hormone releasing hormone
EP0975374B1 (en) * 1996-07-12 2007-12-05 Immunomedics, Inc. Radiometal-binding peptide analogues
CA2283854A1 (en) * 1997-04-22 1998-10-29 The Curators Of The University Of Missouri Gastrin receptor-avid peptide conjugates
WO1998058955A2 (en) * 1997-06-20 1998-12-30 University Of Massachusetts Nuclear matrix targeting peptides and uses therefor
DE69939036D1 (de) * 1998-04-28 2008-08-14 Serono Lab PEG Konjugate von LHRH Analogen
US6656922B2 (en) * 1998-05-28 2003-12-02 Mediplex Corporation, Korea Oral delivery of macromolecules
US6866837B2 (en) * 1998-06-05 2005-03-15 Mallinckrodt Inc. Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors
IT1304501B1 (it) * 1998-12-23 2001-03-19 Bracco Spa Uso di derivati di acidi biliari coniugati con complessi metallicicome "blood pool agents" per l'indagine diagnostica tramite risonanza
GB2355009A (en) * 1999-07-30 2001-04-11 Univ Glasgow Peptides conjugated to bile acids/salts
IT1317862B1 (it) * 2000-02-29 2003-07-15 Bracco Spa Coniugati di acidi biliari con chelati complessi di ioni metallici eloro uso.
CA2405151A1 (en) 2000-04-07 2001-10-18 University Of Maryland, Baltimore Bile acid containing prodrugs with enhanced bioavailability
CA2512310C (en) * 2003-01-13 2012-09-25 Bracco Imaging S.P.A. Improved linkers for radiopharmaceutical compounds

Similar Documents

Publication Publication Date Title
JP2006513247A5 (https=)
CA2512310A1 (en) Improved linkers for radiopharmaceutical compounds
KR101106533B1 (ko) 안정한 방사성의약 조성물 및 제조 방법
JP5683951B2 (ja) 長期間作用性ペプチド類似体のための組成物
JP2008511557A5 (https=)
CN1158133A (zh) 肽衍生的放射性核素螯合剂
JP3795521B2 (ja) ペプチド−キレート化剤複合体
JPH1095737A (ja) ペプチド誘導体
JP2003104998A (ja) ソマトスタチンペプチド
BRPI0717135A2 (pt) Antagonistas de receptores (sstr2) seletivos de so-mastotatina
JP2008525491A5 (https=)
AU2022397307A1 (en) Cleavable radioligands for targeting cell surface receptors and uses thereof
US20230183317A1 (en) Methods of detecting and treating lung damage in respiratory-related viral infections
US7202330B2 (en) RGD (Arg-Gly-Asp) coupled to (neuro)peptides
Du et al. FDA‐approved drugs featuring macrocycles or medium‐sized rings
AU2001268982A1 (en) RGD (arg-gly-asp) coupled to (neuro)peptides
US9493504B2 (en) Radioconjugation method
US10548995B2 (en) Radiolabelling method
WO2005044313A3 (en) Conjugates of angiotensin ii and an imaging moiety
McKenna et al. Cidofovir peptide conjugates as prodrugs
KR20070083815A (ko) 고체상 합성에서 ｓ-알킬-술페닐 보호기
KR20220118464A (ko) 암의 영상화 및 치료법을 위한 개선된 약동학을 갖는 화합물
JP2021523214A5 (https=)
RU2528414C1 (ru) Циклический октапептид, радиофармацевтическое средство на его основе и способ применения радиофармацевтического средства для получения лекарственных (фармацевтических) средств для лечения новообразований, экспрессирующих соматостатиновые рецепторы
US20250346589A1 (en) Radioisotope labeled sstr2-agonists with linkers